Allied Biotech Corporation (TPEX:1780)

Market Cap	3.07B +94.7%
Revenue (ttm)	849.51M +5.3%
Net Income	129.46M +28.3%
EPS	1.34 +27.6%
Shares Out	96.24M
PE Ratio	23.77
Forward PE	n/a
Dividend	1.25 (3.92%)
Ex-Dividend Date	Jul 17, 2025

Volume	95,273
Average Volume	275,300
Open	32.40
Previous Close	32.00
Day's Range	31.60 - 32.40
52-Week Range	16.80 - 35.50
Beta	0.12
RSI	60.18
Earnings Date	May 4, 2026

About Allied Biotech

Allied Biotech Corporation engages in the manufacture and sale of carotenoids worldwide. The company’s products include Beta-Carotene that offers yellow to reddish orange shades to appeal color in various applications; Beta-Apo-8'-Carotenal, which is used as a food colorant, and provides a range of orange to red shades; and Lycopene, which offers a range of red shades as a nutrient for food, dietary supplements, and pharmaceutical products. It also provides Canthaxanthin, which offers a range of shades of reddish orange for food and beverage ap...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 2001
• Employees: 40
• Stock Exchange: Taipei Exchange
• Ticker Symbol: 1780

Financial Performance

In 2025, Allied Biotech's revenue was 849.51 million, an increase of 5.28% compared to the previous year's 806.92 million. Earnings were 129.46 million, an increase of 28.25%.